Geftinat 250mg, Gefitinib of Natco, Genric Iressa

 Geftinat 250mg is a cancer chemotherapy medication. Gefitinib interferes with the growth of cancer cells and slows their growth and spread in the body.
Geftinat 250mg is used in the treatment of non-small cell lung cancer.

Geftinat 250mg by Natco

Possible side effects of Geftinat gefitinib  250mg  ( Genric Iressa)

If you experience any of the following serious side effects from Geftinat, contact your doctor immediately:

• an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
• lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
• severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or
• eye pain or irritation.

Other, less serious side effects may be more likely to occur. Continue taking Geftinat 250mg and talk to your doctor if you experience:

• mild to moderate nausea, vomiting, loss of appetite, or diarrhea;
• skin rash, dryness, itching, or acne; or
• weakness.

Most important information I should know about Geftinat 250mg

Geftinat 250mg should only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents.
Serious side effects have been reported with the use of gefitinib including: allergic reactions (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives); lung problems; liver problems; eye problems; severe nausea, vomiting, loss of appetite, or diarrhea; and others. Talk to your doctor about the possible side effects from treatment with geftinat 250mg .